Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity

Italia Di Liegro, Linda Troeberg, Italia Di Liegro, Alessandra Lo Cicero, Iwona Majkowska, Hideaki Nagase

Risultato della ricerca: Article

31 Citazioni (Scopus)

Abstract

Membrane microvesicle shedding is an active process and occurs in viable cells with no signs of apoptosis or necrosis. We report here that microvesicles shed by oligodendroglioma cells contain an 'aggrecanase' activity, cleaving aggrecan at sites previously identified as targets for adamalysin metalloproteinases with disintegrin and thrombospondin domains (ADAMTSs). Degradation was inhibited by EDTA, the metalloproteinase inhibitor GM6001 and by tissue inhibitor of metalloproteinases (TIMP)-3, but not by TIMP-1 or TIMP-2. This inhibitor profile indicates that the shed microvesicles contain aggrecanolytic ADAMTS(s) or related TIMP-3-sensitive metalloproteinase(s). The oligodendroglioma cells were shown to express the three most active aggrecanases, namely Adamts1, Adamts4 and Adamts5, suggesting that one or more of these enzymes may be responsible for the microvesicle activity. Microvesicles shed by rheumatoid synovial fibroblasts similarly degraded aggrecan in a TIMP-3-sensitive manner. Our findings raise the novel possibility that microvesicles may assist oligodendroglioma and rheumatoid synovial fibroblasts to invade through aggrecan-rich extracellular matrices
Lingua originaleEnglish
pagine (da-a)229-233
Numero di pagine5
RivistaMatrix Biology
Volume31
Stato di pubblicazionePublished - 2012

Fingerprint

Oligodendroglioma
Tissue Inhibitor of Metalloproteinase-3
Metalloproteases
Aggrecans
Fibroblasts
Thrombospondins
Disintegrins
Cell-Derived Microparticles
Tissue Inhibitor of Metalloproteinase-2
Tissue Inhibitor of Metalloproteinase-1
Edetic Acid
Extracellular Matrix
Necrosis
Apoptosis
Membranes
aggrecanase
Enzymes
Crotalus adamanteus proteinase II

All Science Journal Classification (ASJC) codes

  • Molecular Biology

Cita questo

Di Liegro, I., Troeberg, L., Di Liegro, I., Lo Cicero, A., Majkowska, I., & Nagase, H. (2012). Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity. Matrix Biology, 31, 229-233.

Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity. / Di Liegro, Italia; Troeberg, Linda; Di Liegro, Italia; Lo Cicero, Alessandra; Majkowska, Iwona; Nagase, Hideaki.

In: Matrix Biology, Vol. 31, 2012, pag. 229-233.

Risultato della ricerca: Article

Di Liegro, I, Troeberg, L, Di Liegro, I, Lo Cicero, A, Majkowska, I & Nagase, H 2012, 'Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity', Matrix Biology, vol. 31, pagg. 229-233.
Di Liegro, Italia ; Troeberg, Linda ; Di Liegro, Italia ; Lo Cicero, Alessandra ; Majkowska, Iwona ; Nagase, Hideaki. / Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity. In: Matrix Biology. 2012 ; Vol. 31. pagg. 229-233.
@article{baac52c1e8f546ab8bc00c9321412e80,
title = "Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity",
abstract = "Membrane microvesicle shedding is an active process and occurs in viable cells with no signs of apoptosis or necrosis. We report here that microvesicles shed by oligodendroglioma cells contain an 'aggrecanase' activity, cleaving aggrecan at sites previously identified as targets for adamalysin metalloproteinases with disintegrin and thrombospondin domains (ADAMTSs). Degradation was inhibited by EDTA, the metalloproteinase inhibitor GM6001 and by tissue inhibitor of metalloproteinases (TIMP)-3, but not by TIMP-1 or TIMP-2. This inhibitor profile indicates that the shed microvesicles contain aggrecanolytic ADAMTS(s) or related TIMP-3-sensitive metalloproteinase(s). The oligodendroglioma cells were shown to express the three most active aggrecanases, namely Adamts1, Adamts4 and Adamts5, suggesting that one or more of these enzymes may be responsible for the microvesicle activity. Microvesicles shed by rheumatoid synovial fibroblasts similarly degraded aggrecan in a TIMP-3-sensitive manner. Our findings raise the novel possibility that microvesicles may assist oligodendroglioma and rheumatoid synovial fibroblasts to invade through aggrecan-rich extracellular matrices",
keywords = "Membrane vesicles; Aggrecan; Metalloproteinase; ADAMTS",
author = "{Di Liegro}, Italia and Linda Troeberg and {Di Liegro}, Italia and {Lo Cicero}, Alessandra and Iwona Majkowska and Hideaki Nagase",
year = "2012",
language = "English",
volume = "31",
pages = "229--233",
journal = "Matrix Biology",
issn = "0945-053X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity

AU - Di Liegro, Italia

AU - Troeberg, Linda

AU - Di Liegro, Italia

AU - Lo Cicero, Alessandra

AU - Majkowska, Iwona

AU - Nagase, Hideaki

PY - 2012

Y1 - 2012

N2 - Membrane microvesicle shedding is an active process and occurs in viable cells with no signs of apoptosis or necrosis. We report here that microvesicles shed by oligodendroglioma cells contain an 'aggrecanase' activity, cleaving aggrecan at sites previously identified as targets for adamalysin metalloproteinases with disintegrin and thrombospondin domains (ADAMTSs). Degradation was inhibited by EDTA, the metalloproteinase inhibitor GM6001 and by tissue inhibitor of metalloproteinases (TIMP)-3, but not by TIMP-1 or TIMP-2. This inhibitor profile indicates that the shed microvesicles contain aggrecanolytic ADAMTS(s) or related TIMP-3-sensitive metalloproteinase(s). The oligodendroglioma cells were shown to express the three most active aggrecanases, namely Adamts1, Adamts4 and Adamts5, suggesting that one or more of these enzymes may be responsible for the microvesicle activity. Microvesicles shed by rheumatoid synovial fibroblasts similarly degraded aggrecan in a TIMP-3-sensitive manner. Our findings raise the novel possibility that microvesicles may assist oligodendroglioma and rheumatoid synovial fibroblasts to invade through aggrecan-rich extracellular matrices

AB - Membrane microvesicle shedding is an active process and occurs in viable cells with no signs of apoptosis or necrosis. We report here that microvesicles shed by oligodendroglioma cells contain an 'aggrecanase' activity, cleaving aggrecan at sites previously identified as targets for adamalysin metalloproteinases with disintegrin and thrombospondin domains (ADAMTSs). Degradation was inhibited by EDTA, the metalloproteinase inhibitor GM6001 and by tissue inhibitor of metalloproteinases (TIMP)-3, but not by TIMP-1 or TIMP-2. This inhibitor profile indicates that the shed microvesicles contain aggrecanolytic ADAMTS(s) or related TIMP-3-sensitive metalloproteinase(s). The oligodendroglioma cells were shown to express the three most active aggrecanases, namely Adamts1, Adamts4 and Adamts5, suggesting that one or more of these enzymes may be responsible for the microvesicle activity. Microvesicles shed by rheumatoid synovial fibroblasts similarly degraded aggrecan in a TIMP-3-sensitive manner. Our findings raise the novel possibility that microvesicles may assist oligodendroglioma and rheumatoid synovial fibroblasts to invade through aggrecan-rich extracellular matrices

KW - Membrane vesicles; Aggrecan; Metalloproteinase; ADAMTS

UR - http://hdl.handle.net/10447/63781

M3 - Article

VL - 31

SP - 229

EP - 233

JO - Matrix Biology

JF - Matrix Biology

SN - 0945-053X

ER -